The Science Behind Zerona
Erchonia® Laser Scanner, the safest and most researched low-level laser in the world. Initially, designed and FDA approved for use during liposuction, the non-invasive Erchonia laser is applied to emulsify the adipose tissue and release excess fat into the interstitial space. From there, fat is passed through the body during its normal course of detoxification.
Whether performing traditional liposuction procedures or following the new ZERONA® protocol, physicians can be confident they are treating their patients with the safest and most researched low level laser in the world.
The ZERONA® procedure has been proven through a double-blind, randomized, multi-site and placebo-controlled clinical study in which patients, on average, lost 3.64 inches from their waist, hips, and thighs. This result is dramatic compared to the placebo group, which only lost an average of half an inch over the same time period.
This animation shows:
- Healthy adipose cells
- Fat droplets seeping from the cell membrane
- Collapse of adipose cell-emulsification
How Triglycerides and Fatty Acids Escape:
This video shows the formation of a transitory pore forming in the bi-lipid membrane of an adipose cell. This pore is the direct result of safe, low-level laser stimulation and the reason why the triglycerides and fatty acids are able to move into the interstitial space. The tiny pore causes no damage to the cell. It simply allows the fatty content to safely evacuate the cell.
Study shows a decrease in LDL Cholesterol:
Zerona, has been clinically shown to reduce the levels of the hunger-hormone, leptin, and lipoprotein (LDL). A 22 participant pilot study revealed that Zerona not only reduced circumferential inches following a two week treatment phase, but also lowered all patients' leptin levels and reduced low-density lipoprotein numbers in over 50% of the participants in just two weeks.